European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F12%3A%230001725" target="_blank" >RIV/65269705:_____/12:#0001725 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/j.1537-2995.2012.03603.x" target="_blank" >http://dx.doi.org/10.1111/j.1537-2995.2012.03603.x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/j.1537-2995.2012.03603.x" target="_blank" >10.1111/j.1537-2995.2012.03603.x</a>
Alternative languages
Result language
angličtina
Original language name
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization
Original language description
BACKGROUND: Plerixafor with granulocyte-colony-stimulating factor (G-CSF) has been shown to enhance stem cell mobilization in patients with multiple myeloma and lymphoma with previous mobilization failure. In this European named patient program we reportthe experience in insufficiently mobilizing patients diagnosed with nonhematologic diseases. STUDY DESIGN AND METHODS: Thirty-three patients with germ cell tumor (n=11), Ewing sarcoma (n=6), Wiscott-Aldrich disease (n=5), neuroblastoma (n=4), and othernonhematologic diseases (n=7) were included in the study. Plerixafor was limited to patients with previous or current stem cell mobilization failure and given after 4 days of G-CSF (n=21) or after chemotherapy and G-CSF (n=12) in patients who mobilized poorly. RESULTS: Overall, 28 (85%) patients succeeded in collecting at least 2x10(6)/kg body weight (b.w.) CD34+ cells (median, 5.0x10(6)/kg b.w. CD34+ cells; range, 2.0x10(6)-29.5x10(6)/kg b.w. CD34+ cells), and five (15%) patients collec
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Transfusion
ISSN
0041-1132
e-ISSN
—
Volume of the periodical
52
Issue of the periodical within the volume
11
Country of publishing house
US - UNITED STATES
Number of pages
6
Pages from-to
2395-2400
UT code for WoS article
000310977500017
EID of the result in the Scopus database
—